BASF strengthens its commitment to the biopharma and pharmaceutical ingredients industries through a new investment in North America
L-R: Michele Barney (Wyandotte Site Director), Marion Kuhn (Vice President of Business Management, Pharma Solutions), Michael Murphy (Operations Product Manager, Pharma Solutions), Robert A. DeSana (Mayor of Wyandotte, Michigan), Joel Young (RG/PN Research Engineering Services Manager), Benjamin Knudsen (Vice President of Research North America), Artem Gurvich (Head of Business Management, Biopharma). Photo: BASF Corporation
BASF opens its new Good Manufacturing Practice (GMP) Solution Center, in Wyandotte, Michigan. This investment underscores the ongoing commitment of BASF to providing innovative solutions in the biopharma and pharmaceutical ingredients industries, including the reliable supply of bioprocessing ingredients and excipients for biopharma applications as well as small molecules.
This new facility will play a crucial role in the expansion of BASF’s existing network of GMP sites, with innovative systems and processes that ensure products are produced consistently and controlled according to high quality standards. These practices are crucial in the pharmaceutical industry, where the quality of products is paramount for safety and efficacy.
Featuring state-of-the-art clean room packaging, and high-sensitivity analytical testing, this new facility enables close collaboration with customers on customized chemistries for product development. Additionally, improved manufacturing capabilities will allow for more tightly controlled parameters beyond compendial limits and a validated control system that allows for high reproductivity.
Marion Kuhn, vice president of business management, BASF Pharma Solutions states, “Our new GMP Solution Center exemplifies BASF’s dedication to understanding and addressing the evolving needs of our customers in both the biopharma and pharmaceutical industries. This state-of-the-art facility will play a fundamental role in enabling us to collaborate closely with our customers worldwide on product development and GMP manufacturing in ways that are unique to the industry, further strengthening our position as an innovator in the pharmaceutical sector.”
“Wyandotte's new GMP Solution Center is a key example of BASF's commitment to innovative excellence,” said Benjamin Knudsen, vice president of research North America at BASF Corporation. “This expansion not only showcases our dedication to developing customized solutions, but it also highlights our ability to adapt and innovate in response to our customers’ needs. Together, we are paving the way for new innovative solutions.”
Subscribe To Our Newsletter & Stay Updated